KRAS and lung cancer: Interestingly, SDPR was the only DEG that decreased in KRAS-mutant tumor tissues based on GEO datasets (GSE18784, GSE49200), which suggested that the downregulation of SDPR might be a specific signature during the development of KRAS-mutant lung cancer.